Susquehanna International Group
KLDO

Susquehanna International Group’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Susquehanna International Group’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-25,000
Closed -$60K – 14500
2021
Q4 		$60K Buy
25,000
+14,400
+136% +$58.6K ﹤0.01% 12449
2021
Q3 		$58K Sell
10,600
-12,900
-55% -$80K ﹤0.01% 12301
2021
Q2 		$175K Buy
23,500
+11,600
+97% +$82.2K ﹤0.01% 11729
2021
Q1 		$96K Buy
+11,900
New +$130K ﹤0.01% 11882

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Susquehanna International Group's KLDO Position: Q1 2022 in Review

Susquehanna International Group sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q1 2022, closing a stake of 45,490 shares — an estimated $81.2K sold.

Susquehanna International Group first reported a position in KLDO in Q1 2021 and held it in 3 quarters. The position peaked at $303K in Q1 2021. 63 funds tracked by Wall St. Rank hold KLDO as of Q1 2022.

  • Susquehanna International Group reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Susquehanna International Group sold 45,490 Kaleido Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $81.2K.
  • Susquehanna International Group first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Susquehanna International Group's Kaleido Biosciences, Inc. Common Stock position peaked at $303K in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.